PB RCPsych Publications
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals
 QUICK SEARCH:   [advanced]


     


Psychiatric Bulletin (2000) 24: 354. doi: 10.1192/pb.24.9.354-a
© 2000 The Royal College of Psychiatrists
This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Howells, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Howells, R.
Psychiatric Bulletin (2000) 24: 354
© 2000 The Royal College of Psychiatrists


Correspondence

Chlordiazepoxide dosage for alcohol withdrawal

Roger Howells, Consultant Psychiatrist

Maudsley Hospital, Denmark Hill, London SE5 8AZ; e-mail: roger.howells{at}slam-tr.nhs.uk

Sir: I would like to comment on the data of Naik et al (Psychiatric Bulletin, June 2000, 24, 214-215). The initial mean daily dose of chlordiazepoxide equivalents used by general practitioners and specialist alcohol services — namely 45.8 mg and 98.1 mg — approximates to 12 mg four times daily (q.d.s.) and 25 mg q.d.s. respectively. The former is very low, the latter low in more severe dependence.

An inadequate initial daily prescription of chlordiazepoxide can have two adverse consequences:

  1. the emergence of aversive (e.g. agitation and/or withdrawal hallucinations) and/or dangerous (e.g. withdrawal seizures) complications;
  2. an inability of the patient to cope with the withdrawal symptoms, resulting in the resumption of drinking.

Moderate to severely dependent individuals (as judged by the Severity of Alcohol Dependence Questionnaire, Stockwell et al, 1979) may require in the order of 40 mg of chlordiazepoxide q.d.s. and one or two extra ‘as required doses of 40 mg’ for comfortable withdrawal in the first one to two days. Patients and their carers can be given the advice to reduce the amount of chlordiazepoxide if it causes excessive sedation or ataxia. Experience suggests that the as-required medication is needed by most patients at least in the first night when withdrawal symptoms are worse.

Initial undermedication is an iatrogenic cause of non-adherence and needs to be emphasised in the training of those undertaking alcohol detoxification. Furthermore, clinicians managing a patient defaulting after the first day of detoxification should establish (by assertively seeking the patient) whether their initial daily prescription was too low.

References

STOCKWELL, T., MURPHY, D. & HODGSON, T. (1979) The severity of alcohol dependence questionnaire: its use reliability and validity. British Journal of Addiction, 78, 145-155.





This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Howells, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Howells, R.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals